Jennifer L. Davis Procter & Gamble CO (PG) insider trading activity

Jennifer L. Davis is CEO - Health Care of PROCTER & GAMBLE Co. Currently has a direct ownership of 64,990 shares of PG, which is worth approximately $9.95 Million. The most recent transaction as insider was on Aug 19, 2025, when has been sold 8,596 shares (Common Stock) at a price of $157.27 per share, resulting in proceeds of $1,351,892. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 65K

25.07% 3M change

13.38% 12M change

Total Value Held $9.95 Million

Jennifer L. Davis Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 19 2025	SELL Open market or private sale	$1,351,892 $157.27 p/Share	8,596 Reduced 11.68%	64,990 Common Stock
Aug 18 2025	BUY Grant, award, or other acquisition	-	21,518 Added 22.63%	73,586 Common Stock
Apr 29 2025	SELL Open market or private sale	$161,380 $161.38 p/Share	1,000 Reduced 1.89%	51,964 Common Stock
Dec 19 2024	SELL Payment of exercise price or tax liability	$7,810 $169.79 p/Share	46 Reduced 0.09%	52,917 Common Stock
Dec 19 2024	BUY Exercise of conversion of derivative security	$7,810 $169.79 p/Share	46 Added 0.09%	52,963 Common Stock
Oct 02 2024	SELL Open market or private sale	$763,327 $171.65 p/Share	4,447 Reduced 7.76%	52,872 Common Stock
Aug 20 2024	SELL Open market or private sale	$1,053,056 $169.22 p/Share	6,223 Reduced 9.79%	57,319 Common Stock
Aug 19 2024	BUY Grant, award, or other acquisition	-	15,971 Added 20.11%	63,437 Common Stock
Dec 06 2023	SELL Payment of exercise price or tax liability	$7,021 $149.4 p/Share	47 Reduced 0.1%	47,255 Common Stock
Dec 06 2023	BUY Exercise of conversion of derivative security	$7,021 $149.4 p/Share	47 Added 0.1%	47,303 Common Stock
Aug 17 2023	SELL Open market or private sale	$880,568 $152.85 p/Share	5,761 Reduced 10.89%	47,148 Common Stock
Aug 16 2023	BUY Grant, award, or other acquisition	-	12,843 Added 19.53%	52,909 Common Stock
Apr 24 2023	SELL Open market or private sale	$3,717,629 $155.27 p/Share	23,943 Reduced 37.53%	39,860 Common Stock
Apr 24 2023	BUY Exercise of conversion of derivative security	$1,880,004 $78.52 p/Share	23,943 Added 27.29%	63,803 Common Stock
Dec 07 2022	SELL Payment of exercise price or tax liability	$5,519 $149.18 p/Share	37 Reduced 0.09%	39,749 Common Stock
Dec 07 2022	BUY Exercise of conversion of derivative security	$5,519 $149.18 p/Share	37 Added 0.09%	39,786 Common Stock
Oct 03 2022	BUY Grant, award, or other acquisition	-	6,746 Added 14.54%	39,640 Common Stock
Aug 23 2022	SELL Open market or private sale	$4,114,341 $147.95 p/Share	27,809 Reduced 45.81%	32,894 Common Stock
Aug 23 2022	BUY Exercise of conversion of derivative security	$2,532,566 $91.07 p/Share	27,809 Added 31.42%	60,703 Common Stock
Aug 17 2022	SELL Open market or private sale	$1,138,044 $149.33 p/Share	7,621 Reduced 18.81%	32,894 Common Stock
Aug 16 2022	BUY Grant, award, or other acquisition	-	19,021 Added 31.95%	40,515 Common Stock

Also insider at

ABBV

AbbVie Inc. Healthcare

JLD

Jennifer L. Davis

CEO - Health Care

Cincinnati, OH

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PG shares.

Notify only if

Value

Insider Trading

Get notified when an Procter & Gamble CO insider buys or sells PG shares.

Notify only if

Operation

Value

Type

News

Receive news related to PROCTER & GAMBLE Co

Track Activities on PG

Account